Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

S(-)-Carbidopa . monohydrate

Peripheral decarboxylase inhibitor
 
BML-EI265-0100 100 mg 251.00 USD
Do you need bulk/larger quantities?
 
Peripheral decarboxylase inhibitor. Used with L-DOPA as a Parkinson's disease therapeutic.

Product Specification

Formula:C10H14N2O4 . H2O
 
MW:244.2
 
CAS:28860-95-9
 
Purity:≥98% (TLC)
 
Appearance:White solid.
 
Solubility:Soluble in 100% ethanol.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Store solutions at -20°C for up to 3 months.
 
bml-ei265
Please mouse over
bml-ei265

Product Literature References

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation: A.N. Basma, et al.; J. Neurochem. 64, 825 (1995), Abstract;
Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat: P. Cumming, et al.; Biochem. Pharmacol. 50, 943 (1995), Abstract;
New and emerging strategies for improving levodopa treatment: E.S. Tolosa, et al.; Neurology 44, S35 (1994), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Peripheral decarboxylase
By biological activity:
Peripheral decarboxylase Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,